Linked Life Data

19399502

Source:http://linkedlifedata.com/resource/pubmed/id/19399502

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2009-9-17
pubmed:abstractText
Advanced cancers of the bile duct and gallbladder carry an ominous prognosis. Rebeccamycin analogue (RA) is a novel antitumor antibiotic where phase I trials suggested clinical efficacy in patients with biliary cancers.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1432-0843
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
73-8
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
pubmed:affiliation
University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, OH 44106, USA. afshin.dowlati@case.edu
pubmed:publicationType
Journal Article, Clinical Trial, Phase II, Research Support, N.I.H., Extramural